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Abstract 17 
Graphene-based nanomaterials are increasingly engineered as components of biosensors, 18 
interfaces or drug delivery platforms in neuro-repair strategies. In these developments, the mostly 19 
used derivative of graphene is graphene oxide. To tailor the safe development of graphene oxide 20 
nanosheets, we need to model in vitro tissue responses, and in particular the reactivity of microglia, a 21 
sub-population of neuroglia that acts as the first active immune response, when challenged by 22 
graphene oxide. Here, we investigated central nervous system tissue reactivity upon long-term 23 
exposure to graphene oxide nanosheets in 3D culture models. We used the mouse organotypic spinal 24 
cord cultures, ideally suited for studying long-term interference with cues delivered at controlled 25 
times and concentrations. In cultured spinal segments, the normal presence, distribution and 26 
maturation of anatomically distinct classes of neurons and resident neuroglial cells are preserved. 27 
Organotypic explants were developed for two weeks embedded in fibrin glue alone or presenting 28 
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graphene oxide nanosheets at 10, 25 and 50 µg/mL. We addressed the impact of such treatments on 29 
premotor synaptic activity monitored by patch clamp recordings of ventral interneurons. We 30 
investigated by immunofluorescence and confocal microscopy the accompanying glial responses to 31 
graphene oxide exposure, focusing on resident microglia, tested in organotypic spinal slices and in 32 
isolated neuroglia cultures. Our results suggest that microglia reactivity to accumulation of graphene 33 
oxide flakes, maybe due to active phagocytosis, may trimm down synaptic activity, although in the 34 
absence of an effective activation of inflammatory response and in the absence of neuronal cell death. 35 
 36 
1. Introduction 37 
Graphene is a monolayer sheet of carbon atoms, tightly bound in a hexagonal honeycomb 38 
lattice. More specifically, graphene is an allotrope of carbon in the form of a two-dimensional film of 39 
sp2 hybridized carbon atoms (Kostarelos and Novoselov, 2014; Sanchez et al., 2012), characterized 40 
by high mechanical strength and electrical conductivity, combined with optical transparency. In 41 
neurobiology, graphene has been used in surface engineering of regenerative scaffolds to control the 42 
neuro-induction of stem cells (Wang et al., 2012), and in that of neurological interfaces to improve 43 
electrode performance (Kostarelos and Novoselov, 2014; Li et al., 2013; Mao et al., 2013; Wang et 44 
al., 2011).  45 
Graphene oxide (GO) is the most common derivative of graphene. Recently, GO materials 46 
have been successfully designed for drug delivery applications (Liu et al. 2013; Yang et al., 2008, 47 
2011; Baldrighi et al., 2016; Rauti et al., 2018). However, their potential persistence in biological 48 
tissues requires investigating their safety. We have previously (Rauti et al., 2016) reported the ability 49 
of small GO (< 200 nm; s-GO) nanosheets to reduce synaptic activity at glutamatergic synapses 50 
without affecting cultured hippocampal neurons survival. To date, only few studies addressed the 51 
interaction between s-GO nanosheets and synapses (Bramini et al., 2016; Rauti et al., 2016), while 52 
there are scarcely any data on the interactions between neural circuit function, s-GO tissue 53 
accumulation and inflammation. Before any further exploitation of s-GO in synaptic targeting, a 54 
detailed analysis of tissue responses to s-GO exposure is needed.  55 
Mechanistic studies of the interplay between s-GO, the activation of microglia and synaptic 56 
function, may require in vitro models to interrogate central nervous system (CNS) responses at 57 
cellular resolution. Organotypic slices are explant cultures that preserve key, structural elements of 58 
the tissue of origin (Avossa et al., 2003, 2006; Fischer et al., 1998; Furlan et al., 2007; Hailer et al., 59 
1996; Medelin et al., 2016; Schermer and Humpel, 2002; Tscherter et al., 2001) allowing detailed 60 
studies of cellular and subcellular responses, such as inflammatory reactivity and synaptic efficacy 61 
(Medelin et al., 2018), upon chronic treatments, including the exposure to exogenous factors. In the 62 
CNS, the immune response is mediated by resident macrophages called microglia that are 63 
approximately 12 % of the total CNS cells originating from myeloid cells. This subpopulation of 64 
brain cells can switch between two different phenotypes: a ramified phenotype, typical of the resting 65 
state, during which they “monitor” the surrounding environment (Cherry et al., 2014; Davalos et al., 66 
2005; Nimmerjahn et al., 2005) and an amoeboid phenotype, which is induced by antigen-mediated 67 
stimulation. When activated, microglia rapidly changes its surface receptor expression and the 68 
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production of molecules involved in the immune response, like cytokines and chemokines (Fetler and 69 
Amigorena, 2005; Nimmerjahn et al., 2005). Activated microglia may represent an active player in 70 
neuron damage (Block et al., 2007).  71 
We used mouse spinal organotypic cultures to mimic a chronic accumulation of s-GO in the 72 
spinal cord tissue. The s-GO nanosheets were delivered to the spinal tissue upon dilution in the 73 
chicken plasma (fibrin glue) used to embed the explants for culturing, thus allowing s-GO to rapidly 74 
adsorb proteins (Bertrand et al., 2017), to mimic how nanosheets behave in a complex biological 75 
milieu. We patch-clamped ventral interneurons to monitor synaptic transmission. Contextually, using 76 
confocal microscopy we explored the effects of s-GO on innate immunity, in both organotypic slices 77 
and primary isolated microglial cultures. We conclude that chronic accumulation of s-GO, due to 78 
localisation of high doses of the material, significantly affected synaptic activity and the microglia 79 
cell population. Our experiments in isolated microglial cells in culture support the direct response of 80 
these cells to s-GO in these experimental conditions, however in organptypic cultures we did not 81 
detect strong indicators of  a switch toward the pro-inflammatory phenotype. 82 
 83 
2. Materials and Methods 84 
2.1 Preparation of s-GO 85 
Synthesis and characterization of s-GO used in the present study were fully described in a separate 86 
article (Rodrigues et al., 2018). Briefly, 0.8 g of graphite flakes (Graflake 9580, Nacional Grafite 87 
Ltda., Brazil) were oxidized after mixing with 0.4 g of sodium nitrate (Merck-Sigma, UK) and 18.4 88 
mL of sulfuric acid 99.999% (Merck-Sigma, UK), followed by 2.4 g of potassium permanganate 89 
(Merck-Sigma, UK), according to the modified Hummers method, which was described in our 90 
previous work (Ali-Boucetta et al., 2013; Rauti et al., 2016). After mixing for 30 min, 37.5 mL of 91 
water for injections (Fresenius Kabi Ltd., UK) were added dropwise to ensure the safety of the 92 
exothermic reaction taking place. The reaction temperature was further increased to 98 °C, and 93 
maintained for another 30 min. The reaction was terminated after adding 112.5 mL of water for 94 
injections, followed by the dropwise addition of 12.5 mL of hydrogen peroxide 30% (Merck-Sigma, 95 
UK). The resulting mixture was purified by several rounds of centrifugation at 9000 rpm for 20 min, 96 
until the supernatant reached a neutral pH and a viscous orange/brown layer of pure GO appeared on 97 
top of the pelleted oxidation byproducts (Jasim et al., 2016; Rauti et al., 2016). GO was exfoliated 98 
using warm water for injections and purified by centrifugation at 4000 rpm for 20 min to remove any 99 
residual graphitic impurities. The obtained GO dispersion was aliquoted to depyrogenated glass vials, 100 
which were exposed to a water bath sonicator (VWR, UK) operating at 80 W (45 kHz) for 5 min. The 101 
sonicated dispersion was then centrifuged at 13000 rpm for 5 min, and the supernatant was collected 102 
yielding s-GO nanosheets. All procedures were conducted under endotoxin-free conditions, which 103 
were attained by setting the reaction under a laminar flow hood, using depyrogenated glassware and 104 
nonpyrogenic plastic containers (Mukherjee et al., 2016). 105 
Atomic force microscopy (AFM) images of s-GO were acquired using a Multimode 8 microscope 106 
(Bruker, UK), operating in tapping mode using OTESPA tips (Bruker, UK). Twenty µl of s-GO, 107 
diluted to a concentration of 100 µg/mL, were deposited on top of a freshly prepared mica surface 108 
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(Agar Scientific, UK) coated with poly-L-lysine (Sigma-Aldrich, UK), and dried overnight at 37 oC 109 
prior to analysis. Full physicochemical characterization of s-GO is summarized in Figure S1. 110 
 111 
2.2 Preparation of spinal tissue slices and primary glial cultures 112 
Organotypic cultures were obtained from spinal cords isolated from E12 embryonic mouse (C57Bl), 113 
as previously described (Avossa et al., 2003; Furlan et al., 2005, 2007; Usmani et al., 2016). Briefly, 114 
pregnant mice were sacrificed by CO2 overdose and decapitation and fetuses delivered by caesarean 115 
section. Isolated fetuses were decapitated and their backs were isolated from low thoracic and high 116 
lumbar regions and transversely sliced (275 µm) with a tissue chopper. Cultures were fixed on a glass 117 
coverslip (Kindler, EU) with fibrin glue, i.e. reconstituted chicken plasma (Rockland) clotted with 118 
thrombin (Merk). In graphene-treated cultures, s-GO (Rauti et al., 2016) nanosheets were embedded 119 
in the fibrin glue at 10, 25 and 50 µg/mL final concentration. The distribution of s-GO within this 120 
matrix was detected via confocal microscopy under reflection mode (see below; and Patskovsky et 121 
al., 2015). Figure S2 shows the dispersion of s-GO at the different concentrations. Experiments were 122 
performed on control and s-GO treated cultures after 2 and 3 weeks in vitro.  123 
All experiments were performed in accordance with the UE guidelines (Directive 2010/63/UE) and 124 
Italian law (decree 26/14) and were approved by the local authority veterinary service and by our 125 
institution (SISSA-ISAS) ethical committee. All efforts were made to minimize animal suffering and 126 
to reduce the number of animal used. Animal use was approved by the Italian Ministry of Health, in 127 
agreement with the EU Recommendation 2007/526/CE.  128 
Primary brain glial cultures were obtained from P2−P3 rats (Wistar) cortices, as previously described 129 
(Calegari et al., 1999; Rauti et al., 2016). Dissociated cells were plated into plastic 75 cm2 flasks, 130 
incubated (37 °C; 5% CO2) in culture medium consisting of DMEM (Invitrogen), supplemented with 131 
10% FBS, 100 IU/ mL penicillin, and 10 mg/mL streptomycin.  132 
Confluent mixed glial cultures from days in vitro (DIV) 21 to DIV 25 were treated with a trypsin 133 
solution (0.25% trypsin, 1 mM EDTA in HBSS) diluted 1:4 in PBS for 30 minutes at 37 °C and 5% 134 
CO2. The medium was then collected and diluted 1:4 in DMEM supplemented with 10% FBS and 135 
centrifuged for 5 minutes at 200 x g. The pellet was then re-suspended in DMEM supplemented with 136 
10% FBS and mixed glial cultures conditioned medium (50:50) and plated on poly-L-lysine-coated 137 
glass coverslips. Twenty-four hours after trypsinization half of the cultures were incubated with s-GO 138 
at a concentration of 10 µg/mL suspended in the culture medium for 1 or 5 days. 139 
All procedures were approved by the local veterinary authorities and performed in accordance with 140 
the Italian law (decree 26/14) and the UE guidelines (2007/526/CE and 2010/63/UE). The animal use 141 
was approved by the Italian Ministry of Health. All efforts were made to minimize suffering and to 142 
reduce the number of animals used. 143 
 144 
2.3 Electrophysiological recordings 145 
For patch-clamp recordings (whole-cell, voltage clamp mode), a coverslip with the spinal culture was 146 
positioned in a recording chamber, mounted on an inverted microscope (Eclipse TE-200, Nikon, 147 
Japan) and superfused with control physiological saline solution containing (in mM): 152 NaCl, 4 148 
In revi
w
Graphene Oxide Nanosheets and Neural System: from Synaptic Modulation to Neuroinflammation  
 
5 
KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and 10 Glucose. The pH was adjusted to 7.4 with NaOH 149 
(osmolarity 305 mosmol L-1). Cells were patched with glass pipettes (4-7 MΩ) filled with a solution 150 
of the following composition (in mM): 120 Kgluconate, 20 KCl, 10 HEPES, 10 EGTA, 2 MgCl2 and 151 
Na2ATP. The pH was adjusted to 7.3 with KOH (295 mosmol L-1). All electrophysiological 152 
recordings were performed at room temperature (RT; 20-22 °C) and the spontaneous synaptic activity 153 
was recorded by clamping the membrane voltage at –56 mV (not corrected for liquid junction 154 
potential, which was –14 mV). Recordings were performed from ventrally located spinal 155 
interneurons identified on the basis of previously reported criteria (Ballerini et al., 1999; Ballerini 156 
and Galante, 1998; Galante et al., 2000). We detected no differences between controls (n = 45) and s-157 
GO (n = 39) neurons in cell membrane capacitance (70 ± 8 pF controls, 68 ± 6 pF s-GO) and 158 
membrane input resistance (250 ± 28 MΩ controls, 242 ± 20 MΩ s-GO). Spontaneous activity was 159 
also recorded in the presence of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM), bicuculline 160 
(20 µM) and strychnine (10 µM) to pharmacologically discriminate between glutamatergic and 161 
GABAergic PSCs, respectively. To detect miniature post-synaptic currents (mPSCs), TTX (1 µM; 162 
Latoxan, Valence, France) was added. All reagents were purchased from Sigma-Aldrich, if not 163 
otherwise indicated. Data were collected by Multiclamp 700B patch amplifier (Axon CNS, 164 
Molecular Devices) and digitized at 10 kHz with the pClamp 10.2 software (Molecular Devices LLC, 165 
USA).  All recorded events were analyzed offline with the AxoGraph 1.4.4 (Axon Instrument) event 166 
detection software (Axon CNS, Molecular Devices). 167 
 168 
2.4 Immunofluorescence labelling of spinal cord slices  169 
Organotypic cultures were fixed by 4% formaldehyde (prepared from fresh paraformaldehyde; 170 
Sigma) in PBS for 1 hour at RT and then washed in PBS. Free aldehyde groups were quenched in 0.1 171 
M glycine in PBS for 5 min. The samples were blocked and permeabilized in 3 % fetal bovine serum 172 
(FBS), 3 % BSA and 0.3 % Triton-X 100 in PBS for 1 h at RT. Samples were incubated with primary 173 
antibodies (mouse anti-neurofilament H Smi 32, Biolegend, 1:250 dilution; mouse monoclonal anti-174 
GFAP, Invitrogen, 1:500 dilution; rabbit monoclonal anti-caspase 3, Euroclone, 1: 200 dilution; 175 
rabbit polyclonal anti-β-tubulin III, Sigma-Aldrich, 1:250 dilution; rabbit anti Iba1, Wako, 1:250 176 
dilution) diluted in PBS with 5 % FBS at 4 °C, overnight. Samples were then incubated in secondary 177 
antibodies (Alexa 488 goat anti-mouse, Invitrogen, 1:500 dilution; Alexa 594 goat anti-rabbit, 178 
Invitrogen, 1:500 dilution), and DAPI (Invitrogen, dilution 1:200) to stain the nuclei, for 2 h at RT 179 
and finally mounted on 1 mm glass coverslips using Vectashield hardset mounting medium (Vector 180 
Laboratories). Images were acquired using a Nikon C2 Confocal, equipped with Ar/Kr, He/Ne and 181 
UV lasers. Images were acquired with a 40× (1.4 NA) or 60× (1.5 NA) oil-objective (using oil 182 
mounting medium, 1.515 refractive index). Confocal sections were acquired every 500 nm and the 183 
total Z-stack thickness (50 µm) was set such that all emitted fluorescence was collected from the 184 
sample. Regions of interest were confined to the ventral part of slice. Offline analysis was performed 185 
using the open source image-processing package Fiji (Schindelin et al., 2012) and Volocity software 186 
(Volocity 3D image analysis software, PerkinElmer, USA).  187 
 188 
2.5 Immunofluorescence labelling of neuroglia primary cultures 189 
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Primary glial and microglial cultures were fixed by 4 % formaldehyde (prepared from fresh 190 
paraformaldehyde) in PBS for 20 min at RT and then washed in PBS. Free aldehyde groups were 191 
quenched in 0.1 M glycine in PBS for 5 min. The samples were blocked and permeabilized in 5 % 192 
fetal bovine serum (FBS), 0.3 % Triton-X 100 in PBS for 30 min at RT. Samples were incubated 193 
with primary antibodies (mouse monoclonal anti-GFAP, Invitrogen, 1:500 dilution; rabbit anti Iba1, 194 
Wako, 1:250 dilution; mouse monoclonal anti-Brdu, Thermo Fisher, 1:200 dilution) diluted in PBS 195 
with 5 % FBS at 4 °C, overnight. Samples were then incubated in secondary antibodies (Alexa 488 196 
goat anti-mouse, Invitrogen, 1:500 dilution; Alexa 594 goat anti-rabbit, Invitrogen, 1:500 dilution), 197 
and DAPI (Invitrogen, dilution 1:200) to stain the nuclei, for 45 minutes at RT and finally mounted 198 
on 1 mm thick glass coverslips using Vectashield mounting medium (Vector Laboratories). Cells 199 
densities were quantified at 20× (0.5 NA) magnification using a DM6000 Leica microscope (Leica 200 
Microsystems GmbH, Wetzlar, Germany). In order to investigate the internalization of s-GO in 201 
microglial cells, we used the reflection mode property during the confocal acquisition. Images were 202 
acquired using a Nikon C2 Confocal, equipped with Ar/Kr, He/Ne and UV lasers. Images were 203 
acquired with a 40× (1.4 NA) oil-objective (using oil mounting medium, 1.515 refractive index). 204 
Confocal sections were acquired every 200 nm and the total Z-stack thickness 20µm. 205 
 206 
2.6 Bromodeoxyuridine (BrdU) incorporation 207 
Microglial primary cultures were incubated with BrdU (Thermo Fisher) diluted in the culture 208 
medium at a final concentration of 10 µM for 24 hours. Cells were then washed with PBS and fixed 209 
by 4 % formaldehyde (prepared from fresh paraformaldehyde) for 20 minutes at RT and then washed 210 
with PBS (3 times, 2 minutes each). Free aldehyde groups were quenched in 0.1 M glycine in PBS 211 
for 5 min. Cells were then incubated with HCl 1 M for 1 minutes on ice and with HCl 2 M for 15 212 
minutes at 37 °C. Acid was then neutralized with boric acid 0.1 M for 10 minutes at RT. The samples 213 
were then blocked and permeabilized in 3 % fetal bovine serum (FBS) and 0.3 % Triton-X 100 in 214 
PBS for 1h at RT. Samples were incubated with primary antibodies at 4 °C overnight (mouse 215 
monoclonal anti-BrdU, 1:200 dilution; rabbit anti-Iba1, 1:200 dilution). Samples were then incubated 216 
in secondary antibodies (Alexa 488 goat anti-mouse, Invitrogen, 1:500 dilution; Alexa 594 goat anti-217 
rabbit, Invitrogen, 1:500 dilution), and DAPI (Invitrogen, dilution 1:200) to stain the nuclei, for 45 218 
minutes at RT and mounted on 1 mm thick glass coverslips using Vectashield mounting medium 219 
(Vector Laboratories). 220 
 221 
2.7 Microvesicle isolation 222 
Microvesicles shedding and detection by western blotting were performed as previously described 223 
(Rauti et al., 2016).  Microvesicles release was induced in 21 DIV microglial cells by the stimulation 224 
with benzoyl-ATP (bzATP; 100 µM) in saline solution with the following composition: 125 mM 225 
NaCl, 5 mM KCl, 1.2 mM MgSO4, 1.2 mM KH2PO4, 2 mM CaCl2, 6 mM D-glucose, and 25 mM 226 
HEPES/NaOH (pH adjusted to 7.4), for 30 min at 37 °C and 5% CO2. Microvesicles were then 227 
pelleted by centrifugation (Bianco et al., 2009). Negative controls were incubated with saline solution 228 
without the presence of bzATP. MVs were re-suspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 229 
150 mM NaCl, 1 % NP40, 0.1 % SDS), sonicated 3 × 10 s, and then boiled at 95 °C for 5 min. 230 
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Samples were run on a 10 % polyacrylamide gel and were blotted onto nitrocellulose filters 231 
(Millipore, Italy). Filters were then blocked in PBS-Tween-20 (0.1 %) plus 5 % nonfat dry milk and 232 
incubated with the primary antibody antiflotillin-1 (dilution 1:1000) for 16 h at 4 °C. Specific MV 233 
marker flotillin-1 (Al-Nedawi et al., 2008; del Conde et al., 2005) was detected with mouse 234 
monoclonal antiflotillin-1 (dilution 1:1000). After three washes with PBS-Tween, filters were 235 
incubated with peroxidase-conjugated anti-mouse secondary antibody (dilution 1:1000). Optical 236 
density of immunolabeled ECL-exposed protein bands was measured with UVI-1D software. 237 
 238 
2.8 Microglial morphological analysis 239 
For morphological analysis cells were fixed and immunostained for Iba1 and DAPI for nuclei, as 240 
described above and images were acquired with a 40 × oil objective. The quantitative analysis of cell 241 
morphology was performed with the particle analysis feature in Fiji (1.51v) to automatically measure 242 
the area, perimeter and Feret’s maximum diameter. In particular, Feret’s diameter is described as the 243 
greatest distance between any two points along cell perimeter and is considered as an index of cell 244 
length (Caldeira et al., 2014; Kurpius et al., 2006; Mitchell et al., 2018; Torres-Platas et al., 2014; 245 
Zanier et al., 2015). A more ramified cell has a higher value for this parameter, while a more 246 
amoeboid shape is described by a lower value. We also evaluated the transformation index (Caldeira 247 
et al., 2014; Fujita et al., 1996) which is calculated as [perimeter of cell (µm)]2/4π [cell area (µm2)] 248 
and describes the degree of cellular ramification. Cells with long processes and small cell body 249 
display larger values of the transformation index, which depends on the cell shape regardless the cell 250 
size. 251 
 252 
2.9 Measurement of cytokines and chemokines 253 
In a small set of experiments an inflammatory response was induced (Hanisch, 2002), by incubating 254 
organotypic slices, for 6 hours, with a cocktail of the following mouse recombinant cytokines: TNF-α 255 
(R&D Systems, #210-TA/CF), IL-1β (R&D Systems, #M15330), GM-CSF (R&D Systems, 256 
#P04141), 10 ng/mL each, or with lipopolysaccharide (LPS, 1 ng/mL). Inflammatory reaction may be 257 
detected by cytokine and chemokine production. A panel of 12 out of cytokines or chemokines was 258 
measured in organotypic culture supernatants after 2 weeks culturing, by Luminex based technology, 259 
using a customized Procarta plex Immunoassay kit (Invitrogen), following the manufacturer’s 260 
protocol. The following soluble factors were simultaneously measured in 50 µl of supernatant: IL4, 261 
IL6, IL10, IL17, IL21, BAFF, IFNγ, TNFα, CXCL1, CXCL2, CXCL10, MCP1. 262 
 263 
2.10 Statistical Analysis 264 
The results are presented as the mean ± SD, if not otherwise indicated. Statistically significant 265 
difference between two data sets was assessed by t-statistic, in particular by Student’s t-test (after 266 
checking variances homogeneity by Leven’s test) for parametric data and by Mann-Whitney’s test for 267 
non-parametric ones (Statistica 6.0 – StatSoft Italy). Differences among multiple groups were 268 
evaluated by F-statistic with two-way ANOVA, followed by the Holm-Sidak test for multiple 269 
comparison (Sigmaplot 12.0 – Systat Software). 270 
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A statistically significant difference between two data sets was assessed and P < 0.05 was considered 271 
statistically significant.  272 
In box-plots, the thick horizontal bar indicates the median value, the cross indicates the mean value, 273 
the boxed area extends from the 25th to 75th percentiles while whiskers from the 5th to the 95th 274 
percentiles. 275 
 276 
3. Results 277 
3.1 Long-Term Exposure to High Doses of s-GO Impaired Network Activity in Spinal-Cord 278 
Organotypic Slices. We first explored the long-term (2 weeks) exposure of neural tissue to s-GO in 279 
3D tissue cultures. s-GO was delivered to the neural tissue via the fibrin glue, the thick matrix 280 
obtained by chicken plasma and thrombin in which slices are embedded (see Methods), that 281 
represents the explant growth environment. Figure 1A shows a reconstruction at low confocal 282 
magnification of a spinal cord slice after 14 days of growth, labelled for neurofilament H (Smi-32; in 283 
green) and for the nuclei (DAPI, in blue). The entire area of tissue growth is visualized, and it 284 
includes the spinal slice, at the centre, and the outgrowing area comprising the co-cultured dorsal root 285 
ganglia (DRG) and the typical, dense mesh of Smi-32+ neurites in the surrounding outgrowth belt 286 
(Fabbro et al., 2012).  287 
Spinal organotypic slices upon 2 weeks of culturing exhibit an intense spontaneous synaptic 288 
activity (Ballerini and Galante, 1998; Furlan et al., 2007; Streit, 1993). We patch clamped (sketched 289 
in Figure 1B) visually identified ventral interneurons (at holding potential, Vh  of – 56 mV) in control 290 
cultures (n = 45) and in s-GO treated ones (n = 52), and we recorded spontaneous, basal postsynaptic 291 
currents (PSCs). Figure 1C shows representative tracings in control (top) and after exposure to the 292 
highest dose (50 µg/mL) of s-GO (bottom). In all culture groups, PSCs appeared as heterogeneous 293 
inward currents of variable amplitudes, characterized by different kinetic properties (fast decaying 294 
events, with decay time constant (τ) of 6 ± 2 ms and slow decaying events with τ 22 ± 6, n = 15, see 295 
sample in Figure 1C, right panel; Medelin et al., 2018).  296 
The chronic (2 weeks) exposure to low (10 µg/mL) doses of s-GO did not affect PSCs 297 
amplitude and frequency values (39 ± 7 pA and 23 ± 5 Hz, n = 13) when compared to control ones 298 
(42 ± 6 pA and 24 ± 4 Hz, n = 15; plots in Figure 1D). Conversely, higher s-GO doses significantly 299 
(25 and 50 µg/mL, P < 0.05 and P < 0.01, respectively; two-way ANOVA) reduced PSCs frequency 300 
(from 24 ± 6 Hz in control to 14 ± 3 Hz, in s-GO 25 µg/mL, n = 15 and 13; from control 22 ± 8 Hz to 301 
10 ± 2 Hz in s-GO 50 µg/mL, n = 15 and 13; plot in Figure 1D, left). Upon s-GO treatments, PSCs 302 
decay kinetics (fast decaying, τ 5 ± 2 ms and slow decaying τ 26 ± 3, n = 13 at 50 µg/mL, see sample 303 
Figure 1C bottom row, right) and amplitudes were not altered by these treatments (Figure 1D, right). 304 
In 25 and 50 µg/mL s-GO treated cultures we investigated the amount of neuronal apoptosis in 305 
respect to aged-matched controls by measuring the expression of active caspase-3 (Cohen, 1997). 306 
Active caspase-3 positive cells were quantified in the ventral spinal horns (Figure 1E, in red). We 307 
detected a comparative amount of apoptotic cells in all conditions (in control: 15 ± 3 Caspase-3 308 
positive cells/mm2 namely 3.7 % of the total amount of cells, n = 10 visual fields and in s-GO 50 309 
µg/mL; 20 ± 3 Caspase-3 positive cells/mm2, 4.3 % of the cells, n = 10 visual fields; plot in Figure 310 
1E). Thus, s-GO only when delivered at higher concentrations altered synapse function, without 311 
increasing neuronal cell death. 312 
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Miniature synaptic currents (mPSCs; Figure 2) were recorded in a subset of control (n = 12) 313 
and s-GO treated (n = 13) neurons by application of tetrodotoxin (TTX, 1 µM), to block voltage-314 
gated sodium channels. As this treatment impairs the generation of action potentials, mPSCs reflect 315 
the stochastic release of vesicles from the presynaptic terminals at individual synapses impinging 316 
onto the recorded neuron. Their frequency depends on the pre-synaptic release probability and on the 317 
number of synaptic contacts, while their amplitude depends on postsynaptic receptor sensitivity  318 
(Raastad et al., 1992). In neurons exposed to low (10 µg/mL) s-GO, mPSCs frequency was not 319 
affected (from 19 ± 3 Hz in control to 15 ± 3 Hz in s-GO treated slices; plot in Figure 2). When 320 
investigating the impact of higher graphene doses (25 and 50 µg/mL), we detected a significant 321 
difference (P < 0.05 and P < 0.01, respectively; two-way ANOVA) in mPSCs frequency (from 20 ± 3 322 
Hz to 13 ± 2 Hz in s-GO 25µg/mL and from 16 ± 3 Hz to 6 ± 1 Hz in s-GO 50 µg/mL). s-GO did not 323 
affect the amplitude of the recorded events (from 27 ± 6 pA in controls to 32 ± 5 pA in s-GO 10 324 
µg/mL; from 29 ± 5 pA in controls to 27 ± 4 pA in s-GO 25 µg/mL; from 33 ± 8 pA in controls to 30 325 
± 6 pA in s-GO 50 µg/mL).  326 
In s-GO neurons (50 µg/mL) we pharmacologically (see Methods) isolated AMPA-receptor 327 
mediated glutamatergic mEPSCs (n = 13) or GABAA- receptor mediated mIPSCs (n = 13), both 328 
detected as inward currents in our recording conditions (Medelin et al., 2016). mEPSCs and mIPSCs 329 
frequency values were similarly reduced by s-GO when compared to control slices (for mEPSPs in 330 
controls 14 ± 4 Hz, n = 12; in s-GO 7 ± 2 Hz, n = 13; P < 0.05, Student’s t test; histograms in Figure 331 
2, bottom-left panel; for mIPSCs in controls 13 ± 4 Hz, n = 12; in s-GO 5 ± 2 Hz, n = 13; P < 0.05, 332 
Student’s t test; histograms in Figure 2, bottom-right panel).  333 
 334 
3.2 s-GO Exposure at High Doses Induced Microglial Proliferation. To investigate tissue 335 
reactivity accompanying s-GO ability to alter synaptic signalling, we used the highest dose tested, 336 
namely the s-GO at 50 µg/mL. In organotypic slice cultures, neuroglia resident cells are mainly 337 
represented by astrocytes (GFAP positive cells) and microglia (Iba1 positive cells; Medelin et al., 338 
2018).  339 
GFAP-positive astrocytes are not immune cells per se, but can, under certain conditions, 340 
contribute to the immune response (Farina et al., 2007). In organotypic cultures upon 2 weeks of 341 
culturing, these cells are usually characterized by a stellate-like morphology (Figure 3A; Avossa et 342 
al., 2003) and their density was not significantly altered by s-GO treatment (Figure 3A, right 343 
histograms; 500 ± 70 GFAP-positive cells/mm2 in control and 650 ± 90 GFAP-positive cells in s-344 
GO; n = 13 visual fields each). Iba1-positive microglia cells are known mediators of CNS 345 
inflammation. In contrast to astrocytes, the density of Iba1-positive cells was significantly (P < 346 
0.01, Student’s t test) increased in slices exposed to s-GO (47 ± 17 Iba1-positive cells/mm2, n = 10 347 
fields in control and 150 ± 30 Iba1-positive cells/mm2, n = 11 fields for s-GO; Figure 3B).  348 
To further investigate glia cell reactivity to s-GO treatment in complex systems, we measured 349 
from the spinal cord cultures supernatant (n = 6 slices for each conditions) the presence of cytokine 350 
and chemokine after 2 weeks of continuous exposure. In s-GO we detected an increased trend of 351 
expression, when compared to controls, of CXCL2, and MCP1, T lymphocytes and monocytes recall 352 
factors, and IL6, IL10, BAFF and TNFα, cytokines responsible for pro-inflammatory responses (IL6, 353 
TNFα), regulatory function (IL10) and homeostatic B cell survival (BAFF), however the profiles of 354 
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soluble factors production obtained from our analysis, did not reach statistical significance (Figure 355 
3C). These observations are in line with a limited or even absent sustained activation of microglial 356 
cells toward both polarized forms: M1 and M2, or most probably toward an intermediate one (Kabba 357 
et al., 2018).  358 
 359 
3.3 s-GO Exposure Induces Microglial Proliferation in Neuroglial Cultures. The increased 360 
density of microglial cell in the absence of significant increased production and release of 361 
chemokines and cytokines after 2 weeks exposure to high s-GO dose, prompted us to directly 362 
investigate the effects of s-GO on microglial cell types in isolated glial preparations, obtained from 363 
early post-natal rats (P2-P3). Due to the relatively low-cell density typical of cultures comprising 364 
isolated Iba1-positive cells, as shown in Figure 4A (control), we exposed the cells for 5 days to a 365 
lower (10 µg/mL) dose of s-GO. s-GO readily increased Iba1-positive cell-density, as shown in 366 
Figure 4A, a response reminiscent of the one observed in organotypic slices (Figure 3B). In order to 367 
assess whether s-GO sheets induced microglia reactivity, we analysed the cellular shape, a 368 
traditionally accepted index of the phenotypes microglia acquires when entrained in tissue responses. 369 
In particular, a highly ramified shape is linked to a surveillant state in which microglia actively 370 
monitors the surrounding environment. On the other hand, an amoeboid phenotype may indicate the 371 
transition to the activated, pro-inflammatory state (Saijo and Glass, 2011). Consistent with a 372 
transformation from a ramified to an amoeboid phenotype, the perimeter, Feret’s maximum diameter 373 
and transformation index (plot in Figure 4B), significantly decreased (Pperimeter<0.0001, PFeret’s 374 
diameter=0.0035, Ptransformation index<0.0001; Mann-Whitney test) after 6 days of s-GO exposure, 375 
compared to control  (n = 10 visual fields for both conditions; 3 different cultures series). The 376 
measured parameters reliably describe morphological changes and cell length. In particular, the 377 
Feret’s maximum diameter is defined as the highest distance between any two points along the cell 378 
perimeter while transformation index describes cellular ramification.  379 
Next, we analysed the number of cycling cells present in each culture group (control and s-380 
GO). For this purpose, cells were pulsed at 24 h and at 5 days with 10 mM bromodeoxyuridine 381 
(BrdU) prior to fixation. The number of cells that had incorporated the nucleotide analogue was then 382 
assessed by immunofluorescence, using anti-BrdU-specific antibodies. In Figure 4C the box plot 383 
shows the BrdU+/Iba1+ ratio, an index of microglial cells that incorporated BrdU in the newly 384 
synthesized DNA during cell division, providing a quantitative measure of proliferative capacity of 385 
cells (Nowakowski et al., 1989). The higher BrdU+/Iba1+ ratio was already significant at 24 hours of 386 
s-GO exposure (medianGO= 0.85; mediancontrol=0.08), suggesting an early interaction of microglia 387 
with small graphene sheets. The increased proliferation was more pronounced after five days of 388 
incubation with s-GO (medianGO= 0.2; mediancontrol=0.45; P < 0.001, Mann-Whitney test, for both 389 
time points; n=10 fields for each condition; 4 different cultures). 390 
Microvesicles (MVs), released from almost all cell brain types, are, in general, an emerging 391 
intercellular communication over long-range distance. In particular, MVs discharged by microglial 392 
cells represent a secretory pathway for inflammatory cytokine (Turola et al., 2012) potentially 393 
promoting propagation of neuroinflammatory responses in the brain. We measured the release of 394 
MVs from isolated microglial cultures in control or exposed to s-GO by western blot analysis for the 395 
protein flotillin-1, a marker of lipid rafts that are specific plasma membrane regions were the 396 
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probability of MVs release is higher (Figure 4D; Rauti et al., 2016). Pharmacological stimulation by 397 
bzATP induces only a slight release of MVs in isolated microglial cells, as depicted by the 398 
particularly weak signal in the specific band (Figure 4D).  Interestingly, bzATP stimulation in the 399 
presence of s-GO triggers a massive microglia shedding of MVs, shown by the high intensity of the 400 
band (Figure 4D).  401 
 402 
3.4 Localization of s-GO in microglial cells. We then directly investigated the fate of s-GO in 403 
isolated microglia cultures using confocal microscopy reconstructions. Iba1-positive cells (2 different 404 
culture series) were exposed for 3 days to s-GO (10 µg/mL). We tested the presence of s-GO sheets 405 
within Iba1 positive cells by operating the confocal microscopy under reflection mode, which allows 406 
the visualization of s-GO (Jung et al., 2007; Kim et al., 2010; Bramini et al., 2016; Chiacchiaretta et 407 
al., 2018). Figure 5A shows confocal reconstructions of control and treated Iba1 positive cells. In s-408 
GO-treated cells, GO nano-sheet aggregates (in yellow, reflection mode) were detected inside 409 
microglial cells (in grey, Iba1+) by z-stack reconstruction (Figure 5, top panels: 40 ×; 100 × 100 µm2 410 
visualized area). In Figure 5, high magnification confocal micrographs (control and s-GO treated, 411 
bottom panels) are shown (60 ×; 50 × 50 µm2 visualized area) depicting a single microglia (grey) cell 412 
co-localisation with the reflected signal of graphene (yellow). The orthogonal view of the z-413 
projection shows the XZ and YZ planes (bottom side and right side of the z-stack reconstructed 414 
image, respectively) of the acquired fields. As expected from cells that act as macrophages, the 415 
material were internalized and stocked inside the cell, forming small aggregates, appreciable by the 416 
orthogonal reconstruction. The signal of s-GO was not present in control cells, either in the z-stack 417 
reconstruction or in the orthogonal planes (Figure 5, left panels). 418 
 419 
 420 
4. Discussion  421 
 422 
We used here organotypic spinal cord cultures to test tissue responses to s-GO prolonged 423 
exposure. In particular, we were interested in assessing microglia reactivity in cultured neural 424 
explants, where immune resident cells are present, but not supported by the peripheral ones.  425 
Organotypic spinal slices represent a biological model of segmental spinal microcircuit useful for 426 
studying the dynamics of intrasegmental processes. A long series of studies has indicated that the 427 
organotypic cultures from mouse spinal cord represent a valuable in vitro model system to study the 428 
mechanisms of development, neurogenesis, glial differentiation, myelination, muscle formation, and 429 
synaptogenesis leading to early post natal features, upon 2 weeks of culturing (Avossa et al., 2003; 430 
Rosato-Siri et al., 2004; Fabbro et al., 2007; Sibilla et al., 2009; Furlan et al., 2007; Medelin et al., 431 
2016). More recently, we confirmed the presence of heterogeneous neuroglial cells after 2 weeks of 432 
in vitro growth and we further documented in organotypic spinal tissue the induction, by short-term 433 
incubation with pro-inflammaotry CKs cocktail, of a reliable release of cytokines and chemokines, 434 
mostly due to the local generation and delivery of inflammatory factors (Medelin et al., 2018). Thus, 435 
our experimental model is ideally suited to dissect spinal resident cells ability in modulating local 436 
inflammatory tissue reactivity. 437 
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The major result of the present investigation is that the long-term accumulation of s-GO 438 
(when delivered at high doses) affected resident microglia and, in the absence of an effective 439 
clearance, may induce a subtle, although chronic, reactive state, potentially trimming down synaptic 440 
activity, as physiologically occurring during development (Paolicelli et al., 2011). In fact, in our 441 
experiments, both GABAR- and AMPAR-mediated mPSCs were reduced in frequency upon s-GO 442 
exposure at high concentrations. The reduction in miniatures’ frequency, but not in their amplitude, 443 
strongly suggests a reduction in the number of synapses or of release sites (Rauti et al., 2016). This 444 
down-regulation of synapses is apparently not due to a general cell membrane disruption or to 445 
neuronal apoptosis. In fact, we never detected alterations in basic electrophysiological parameters, 446 
reflecting neuronal health and membrane integrity (Carp, 1992; Djuric et al., 2015). This indicated, 447 
together with the absence of up-regulated apoptosis that the synaptic events diminished not as a 448 
consequence of direct neuronal damage brought about by s-GO.  449 
In organotypic slices, both glutamate- and GABA-mediated synapses were down-regulated by 450 
s-GO, this result differs from our previous report, where s-GO down-regulated selectively 451 
glutamatergic release sites in hippocampal cultures (Rauti et al., 2016). Considering the similarity of 452 
the s-GO batch used here compared to our previous study (Figure S1), the lack of specific synaptic 453 
targeting may be related to several factors, such as the diverse CNS regions tested, i.e. ventral spinal 454 
cord vs hippocampus, the initially more immature stage of network and synapse development 455 
(embryonic vs postnatal) or the s-GO higher concentrations. In this context, it is relevant to note the 456 
s-GO delivery modality used here: s-GO was accumulated in the fibrin glue embedding the spinal 457 
culture and, presumably, was from here released along 2 weeks of culturing. Thus the potential 458 
formation of a protein corona might have affected the nanoparticle biological fate (Hadjidemetriou et 459 
al., 2015) favouring active phagocytosis by neuroglia and preventing the direct synapse interference 460 
described in our previous report  (Rauti et al., 2016). It is temptive to speculate that the presence in 461 
the spinal explants of resident neuroglia resulted in active phagocytosis restricted to intrinsic 462 
microglia, without the involvement of blood cells such as macrophages. Such an activation could 463 
have induced a generic microglia response, known as synaptic stripping, ultimately leading to 464 
indiscriminate synapse reduction (Kettenmann et al., 2013).  465 
In spinal organotypic slices exposed to s-GO, the presence of tissue reactivity is indicated 466 
only by the observed increase in microglia cell-density, in the absence of increased GFAP+ 467 
astrocytes, suggesting only a mild state of reactivity (Liddelow et al., 2017; Okada et al., 2018; 468 
Olson, 2010). Interestingly, the cytokines and chemokines profiles measured in organotypic cultures 469 
supernatant, although slightly altered, were not significantly increased after 2 weeks of s-GO 470 
exposure. In this regard, we did not found an increase in IL-6, that is produced by astrocyte 471 
following, for example, a proinflammatory stimulation (Ulivieri et al., 2016). Therefore, in this 472 
model, we may hypothesize that microglial proliferative response with no significant variation in 473 
cytokines production after 2 weeks, does not involve a shift into the M1 phenotype.  474 
 The results in this study obtained with isolated Iba1+ cells are in support of a direct activation 475 
of microglial cells as a consequence of active s-GO phagocytosis. s-GO boosted microglia 476 
proliferation leading to a significantly higher cell density in pure neuroglia cultures, accompanied by 477 
the typical morphological switch from a ramified to an amoeboid phenotype (Cherry et al., 2014; 478 
Kettenmann et al., 2011; Nimmerjahn et al., 2005; Saijo and Glass, 2011), suggestive of an active 479 
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role of Iba1-positive cells in the tissue reaction to graphene, even in the virtual absence of other cell 480 
types. The direct activation of microglia was apparently related to fast internalization of s-GO flake 481 
aggregates that occurs during the first 24h after the exposure.  482 
 We thus suggest that s-GO, accumulated via the fibrin glue, activates resident microglia 483 
phagocytosis. This hypothesis is also supported by the observation that pure microglial cultures 484 
grown and exposed to s-GO in a serum-free medium did not show a proliferation boost comparable 485 
to that found in the presence of FBS (Figure S3). As already discussed above, the interaction of 486 
nanoparticles such as s-GO with biological fluids may affect their fate and effectiveness. In fact, the 487 
corona formation takes place not only in the presence of plasma proteins like fibrinogen but also with 488 
proteins present in the serum (Gräfe et al., 2016). Therefore, the proliferative response found in both 489 
pure microglial cultures and organotypic slices exposed to s-GO, despite their different origin and 490 
architecture, may be explained by an increase of the efficacy in the uptake of the material (Walkey et 491 
al., 2012) by microglia and mediated by s-GO interactions with the proteins pool of plasma and 492 
serum.  493 
 An additional indication of microglia reactivity in s-GO was provided by the increased release 494 
of shed vesicles induced by bzATP. MVs released by microglia have been reported to affect synaptic 495 
activity, mainly acting at the presynaptic site of the excitatory synapses, but increasing synaptic 496 
activity and glutamate release in primary cultures (Antonucci et al., 2012) thus it seems unfeasible 497 
that the down-regulation in synaptic activity detected in this study be mediated by MVs release.  498 
 One possibility is that, in the current experimental conditions, the global reduction in synaptic 499 
activity is mostly due to the emergence of chronic, although mild, tissue reactivity. Such reactivity 500 
follows microglia phagocytic activity of protein-decorated s-GO flakes. Ultimately, we have to ask 501 
ourselves whether these data indicate a potential in vivo inflammatory response due to s-GO sheets. 502 
There are several relevant aspects that limit reporting it as an inflammatory response. First of all, the 503 
conditions we tested involved the delivering of s-GO to a “closed” biological system, allowing only 504 
resident macrophages to interact with it and limiting the contribution of neighbour tissues in the 505 
interaction with this material, as it would happen in an in vivo model. The lack of significance in the 506 
chemokine and cytokine increase in concentration suggests a mild immune response that may not 507 
necessarily lead to a pathological inflammatory state or alternatively indicates a return to a 508 
physiological condition, from an intermediate immune activation. Last, astrocytes, which depend on 509 
microglia activation to be polarized to pro-inflammatory cells did not show, in this context, reactive 510 
gliosis.  To note, a recent report (Song et al., 2014) investigated microglia pro- and/or anti-511 
inflammatory responses when challenged by different graphene structures, and documented anti-512 
inflammatory effects of 3D-graphene foams.  513 
 514 
 Microglia produces immune mediators secondary to neuronal stimulation, (i.e. tissue injury), 515 
or following a direct stimulus to microglia itself. Here we report an increased proliferation rate of 516 
Iba1-positive cells, suggestive of microglia activation, and consistent with morphological 517 
observations. However, the detected cell activation seems to involve a group of cells, not all of them, 518 
and this may explain the fact that we observed only a trend toward increased production of immune 519 
factors, without significant variations. We may hypothesize that the fraction of activated microglia 520 
includes cells in direct contact to s-GO. Indeed, microglia is often reported to function similarly to 521 
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other myeloid cells, the macrophages, able to scavenge the environment, perform phagocytosis, 522 
antigen presentation and to react to contact with nano materials (Aldinucci et al., 2013; Jin and 523 
Yamashita, 2016) in order to maintain CNS homeostasis, with both detrimental and beneficial 524 
effects. It is important to underline that eventually the pro-inflammatory molecules, present before 525 
and after s-GO contact, were not inducing astrogliosis. Therefore, as a side effect, our in vitro model 526 
allows the direct observation and study of material/neuron interactions in the presence of glial cells, 527 
and also simulates accumulation of material in CNS providing useful insights on the potential 528 
consequences.   529 
The function of microglia, brain macrophages, is still poorly understood. In mice there are 530 
at least two subtypes: inflammatory and non-classical patrolling cells (Nimmerjahn et al., 2005), 531 
and also a CNS region-dependent microglial heterogeneity has been suggested, suggesting that 532 
microglia, although in many different ways, is constantly activated. In this complex picture, we 533 
were interested in investigating whether s-GO induced an inflammatory reaction. Our results 534 
indicate that this was not the case. Further studies should indeed address the interplay between 535 
microglia and s-GO, for example by single cell RNA sequencing (Matcovitch-Natan et al., 2016), 536 
a method that has sufficient sensibility to determine the functional/phenotypic response of these 537 
important brain-macrophage cell population.   538 
 539 
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5. Figures 541 
Figure 1. s-GO reduced basal synaptic activity in a dose-response fashion without inducing cell 542 
death in organotypic ventral horns. In (A), low magnification confocal micrograph of a spinal cord 543 
slice culture (14 DIV) immune-labelled for neurofilament H (SMI-32; in green) and nuclei (DAPI; in 544 
blue). Scale bar 500 µm. The arrow head indicates the ventral fissure, localizing the ventral horns, 545 
while the arrows the co-cultured DRGs. In (B), sketch of the experimental setting for ventral 546 
interneuron single cell recordings (modified with permission from Usmani et al., 2016). In (C), 547 
tracings represent spontaneous synaptic activity recorded from ventral interneurons in Control (top) 548 
and s-GO treated slices (bottom; 50 µg/mL). On the right panel, isolated fast and slow PSCs are 549 
shown superimposed (electronic average trace superimposed in white) for the control (top) and s-GO 550 
treated (bottom) recordings (same cells as above). In (D), the plots summarize the average PSCs 551 
frequency (left) and amplitude (right) values; note the reduction in PSC frequency upon s-GO 552 
treatments (25 and 50 µg/mL) (* P < 0.05 and ** P < 0.01). In (E), confocal micrographs visualize 553 
caspase-3 positive cells (in red) in the ventral horns, counter-stained for β-tubulin III (in green, to 554 
visualize neurons) in Control (left) and s-GO (50 µg/mL; right) treated slices. Nuclei are visualized 555 
by DAPI (blue). Scale bar: 50 µm. The column plot summarizes the density of caspase and β-tubulin 556 
double positive cells; note the absence of statistical significant differences between the two 557 
conditions.       558 
 559 
Figure 2. Miniature synaptic currents are down regulated by s-GO in organotypic ventral 560 
horns. Sample tracings are mPSCs recorded in Control and s-GO (50 µg/mL) treated cultures (top 561 
left panel). Top right: plot reporting mPSCs frequency values in control and in the three different s-562 
GO concentrations tested. Note that s-GO treatments (25 and 50 µg/mL) significantly decreased the 563 
frequency of mPSCs (* P < 0.05 and ** P < 0.01). Bottom: column plots summarize the average 564 
values of AMPA-glutamate (left; mEPSCs) and GABAA (right, mIPSCs) receptor mediated 565 
miniature events, pharmacologically isolated. In s-GO treatments (50 µg/mL) a significant decrease 566 
in the frequency of both types of miniature was detected (* P < 0.05 and ** P < 0.01, respectively). 567 
 568 
Figure 3. Tissue reactivity in organotypic spinal cultures exposed to s-GO at high dose. In (A), 569 
GFAP immune-labelling to visualize astrocytes in Control and s-GO treated slices (50 µg/mL). Both 570 
cultures were labelled for GFAP (in green) and nuclei (DAPI; in blue) Scale bar 100 µm. Note that 571 
the GFAP+ cell density did not differ between the two conditions (column plot). In (B), 572 
immunofluorescence images are shown to visualize glial and microglial cells in Control and s-GO 573 
(50 µg/mL) treated slices (anti-Iba1, in red; anti-GFAP in green; DAPI in blue). Scale bar 50 µm. 574 
Note that Iba1+ cell density was significantly (** P < 0.01) increased by s-GO (50 µg/mL; right 575 
column plot). (C), Plots summarize the Milliplex assay measures to assess the production of the 576 
following cytokines in organotypic culture supernatant: IL6, IL10, TNF and BAFF and chemokines: 577 
CXCL1, CXCL2, CXCL10 and MCP1 in the presence or absence of s-GO, after 2 weeks in vitro. 578 
Column graphs report mean values ± SEM of 5 independent experiments.  579 
 580 
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Figure 4. Increased cell reactivity in pure microglia cell cultures exposed to s-GO. In (A), 581 
immunofluorescence micrographs visualize microglia by Iba1 labelling (in red) in Control and s-GO 582 
treated cultures (10 µg/mL). Scale bar 50 µm. The column graph summarizes microglial density in 583 
the two conditions. Note that Iba1+ cell density is significantly (*** P < 0.001) higher in cultures 584 
treated by s-GO. In (B), high magnification confocal micrographs of Iba1+ cells highlight their 585 
morphology in the two conditions. The right column plots summarizes perimeter, Ferret’s maximum 586 
diameter and transformation index, parameters that describe cellular ramification. All of them are 587 
significantly reduced after s-GO exposure (***Pperimeter < 0.0001, **PFeret’s diameter < 0.001, 588 
***Ptransformation index < 0.0001; Mann-Whitney test). 589 
In (C), box plots show the brdU+/Iba1+ ratio measured in isolated microglial cultures 24 h and 5 590 
days after s-GO exposure (10 µg/mL) (*** P < 0.001). In (D), western blot analysis of the MVs 591 
marker flotillin-1 in each condition. Microvesicles were isolated from glial cultures incubated with s-592 
GO (10 µg/mL) for 6 days and then treated or not with bzATP.  593 
 594 
Figure 5. s-GO activates microglia phagocytosis in pure neuroglia cultures. Representative 595 
confocal reconstruction of microglial cells in Control or s-GO (10 µg/mL) treated cultures. Scale bar 596 
20 µm. In the bottom panel, for both conditions a 60 × zoom (50 × 50 µm field) of a single microglial 597 
cell is shown. Scale bar 20 µm. Cultures are immunostained for Iba1 (in grey), and DAPI (in blue), s-598 
GO is visualized by the reflection mode of the confocal system (in yellow). s-GO sheets are visible as 599 
aggregates coloured in yellow inside the cell. 600 
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